India to United Arab Emirates: Actinomycin Export Trade Route
India has recorded 26 verified shipments of Actinomycin exported to United Arab Emirates, representing a combined trade value of $30.6K USD. This corridor is served by 13 active Indian exporters, with an average shipment value of $1.2K USD. The leading Indian exporter is INVEX HEALTH PRIVATE LIMITED, which accounts for 67% of total export value with 1 shipments worth $20.5K USD. On the buying side, M S WORLD HEALTH ORGANIZATION is the largest importer in United Arab Emirates with $20.5K USD in purchases. The top 3 suppliers — INVEX HEALTH PRIVATE LIMITED, CITRO PHARMA PRIVATE LIMITED, RMPL PHARMA LLP — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Arab Emirates Actinomycin corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $30.6K USD. The route is dominated by INVEX HEALTH PRIVATE LIMITED, which alone accounts for roughly 67% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 13 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 7.38%, placing it at rank #9 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in United Arab Emirates include M S WORLD HEALTH ORGANIZATION, TO THE ORDER, TO THE ORDER OF INVOICE and 14 others. M S WORLD HEALTH ORGANIZATION is the single largest importer with 1 shipments valued at $20.5K USD.
